Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT01275274Phase 2Withdrawn
Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Principalinvestigator
NCT01275287Phase 2Withdrawn
Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

UNC Kidney Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maria Antonietta D'Agostino

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Moderately Similar
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

mo Wang

Children's Hospital of Chongqing Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Benjamin Terrier, MD, PhD

AP-HP - Service médecine interne

Moderately Similar
1 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Fadi Fakhouri, Pr

Nantes University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Liyun Zhang, M.D

Shanxi Bethune Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Patrick BLANCO, Prof

University Hospital, Bordeaux

Moderately Similar
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Ulrich Specks, MD

Mayo Clinic

Moderately Similar
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Carol A Langford, MD, MHS

The Cleveland Clinic

Moderately Similar
2 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score30%

Vimal Derebail, MD

University of North Carolina, Chapel Hill

Moderately Similar
2 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)University of North Carolina, Chapel Hill
Similarity Score30%

Huji Xu, Ph.D, MD

Shanghai Changzheng Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01275274Phase 2PrincipalInvestigator

Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Withdrawn
NCT01275287Phase 2PrincipalInvestigator

Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Withdrawn

All 2 trials loaded